LSKB's business strategy is focused on development of a next generation cancer drug and providing product development services to international pharmaceutical companies.

Developing products in the life-science industry requires extensive resources and in depth experience. LSKB management has extensive international experience in pharmaceutical product development.  This experience includes business development, US, EU and Korean regulatory practices, and preclinical and clinical development.  LSKB management is leveraging its experience, reputation and contacts to build a unique diversified business with opportunities to develop new health care products.

LSKB was founded in 2005 and is a privately held corporation based in Salt Lake City, Utah, with offices in the US and Korea.